Molecular characterization of Epstein-Barr virus associated with classical Hodgkin's lymphoma in Tunisia: Prevalence of the LMP1 oncogene deletions and a and B viruses strains;Caractérisation moléculaire du virus d'Epstein-Barr associé au lymphome de Hodgkin classique en Tunisie: Prévalence des délétions de l'oncogène LMP1 et des souches virales A et B

Annales de Biologie Clinique

Volumn 63, Issue 2, 2005, Pages 193-199

  Trimeche, M ^a   Korbi, S ^a   Ziadi, S ^a   Amara, K ^a   Boniver, J ^b   De Leval, L ^b  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b CHU SART TILMAN   (Belgium)

Author keywords

EBNA 3C; Epstein Barr virus; Hodgkin's lymphoma; Latent membrane protein 1 deletion; PCR; Tunisia; Typing of EBV

Indexed keywords

EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; MATRIX PROTEIN; ONCOPROTEIN; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; CHILD; COMPARATIVE STUDY; EPSTEIN BARR VIRUS; FEMALE; GENE DELETION; GENETICS; GENOTYPE; HODGKIN DISEASE; HUMAN; LYMPHATIC SYSTEM DISEASE; MALE; MIDDLE AGED; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; SEX DIFFERENCE; STATISTICAL ANALYSIS; TUNISIA; VIROLOGY; VIRUS LATENCY;

ADOLESCENT; ADULT; AGED; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DATA INTERPRETATION, STATISTICAL; DNA, VIRAL; FEMALE; GENE DELETION; GENOTYPE; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; LYMPHATIC DISEASES; MALE; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; POLYMERASE CHAIN REACTION; PREVALENCE; SEX FACTORS; TUNISIA; VIRAL MATRIX PROTEINS; VIRUS LATENCY;

HUMAN HERPESVIRUS 4;

EID: 15944380105     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. IARC working group on the evaluation of carcinogenic risks to humans. Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. Lyon : IARC Press, 1997.
2. Glaser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virus-associated Hodgkin's disease : epidemiologic characteristics in international data. Int J Cancer 1997 ; 70 : 375-82.
3. Delsol G, Brousset P, Chittal S, Rigal-Huguet F. Correlation of the expression of Epstein-Barr virus-latent membrane protein and in situ hybridization with biotinylated Bam HI-W probes in Hodgkin's disease. Am J Pathol 1992 ; 140 : 247-53.
4. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985 ; 43 : 831-40.
5. Hu LF, Zabarovsky ER, Chen F, et al. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP-1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 1991 ; 72 : 2399-409.
6. Chen ML, Tsai CN, Liang CL, et al. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992 ; 7 : 2131-40.
7. Leung SY, Yuen ST, Chung LP, Chan AS, Wong MP. Prevalence of mutations and 30-bp deletion in the C-terminal region of Epstein-Barr virus latent membrane protein-1 oncogene in reactive lymphoid tissue and non-nasopharyngeal EBV-associated carcinomas in Hong Kong Chinese. Int J Cancer 1997 ; 72 : 225-30.
8. Knecht H, Bachmann E, Brousset P, et al. Deletions within the LMP-1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993 ; 82 : 2937-42.
9. Sandvej K, Peh SC, Andresen BS, Pallesen G. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases : high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 1994 ; 84 : 4053-60.
10. Knecht H, Raphael M, McQuain C, et al. Deletion variants within the NF-kB activation domain of the LMP1 oncogene prevail in acquired immunodeficiency syndrome-related large cell lymphomas and human immunodeficiency virus-negative atypical lymphoproliferations. Blood 1996 ; 87 : 876-81.
11. Knecht H, Martius F, Bachmann E, et al. A deletion mutant of the LMP-1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma. Leukemia 1995 ; 9 : 458-65.
12. Chang YS, Su IJ, Chung PJ, et al. Detection of an Epstein-Barr virus variant in T-cell lymphoma tissue identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanaise population. Int J Cancer 1995 ; 62 : 673-7.
13. Chen WG, Chen YY, Bacchi MM, Bacchi CE, Alvarenga M, Weiss LM. Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue : type A with a high prevalence of deletions within the latent membrane protein gene. Am J Pathol 1996 ; 148 : 17-23.
14. Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M. Epstein-Barr virus latent membrane protein-1 oncogene deletions : correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996 ; 88 : 242-51.
15. Santon A, Martin C, Manzanal AI, Preciado MV, Bellas C. Paediatric Hodgkin's disease in Spain : association with Epstein-Barr virus strains carrying latent membrane protein-1 oncogene deletions and high frequency of dual infections. Br J Haematol 1998 ; 103 : 129-36.
16. Klein C, Rothenberger S, Niemeyer C, et al. EBV-associated lymphoproliferative syndrome with a distinct 69 base-pair deletion in the LMP-1 oncogene. Br J Haematol 1995 ; 91 : 938-40.
17. Tacyildiz N, Cavdar AO, Ertem U, et al. Unusually high frequency of a 69-bp deletion within the carboxy terminus of the LMP1 oncogene of Epstein-Barr virus detected in Burkitt's lymphoma of Turkish children. Leukemia 1998 ; 12 : 1796-805.
18. Dirnhofer S, Angeles-Angeles A, Ortiz-Hidalgo C, et al. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue. Hum Pathol 1999 ; 30 : 781-7.
19. Kim I, Park ER, Park SH, Lin Z, Kim YS. Characteristics of Epstein-Barr virus isolated from the malignant lymphomas in Korea. J Med Virol 2002 ; 67 : 59-66.
20. Hu LF, Chen F, Zheng X, et al. Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene 1993 ; 8 : 1575-83.
21. Li SN, Chang YS, Liu ST. Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus. Oncogene 1996 ; 12 : 2129-35.
22. Dolcetti R, Quaia M, Gloghini A, et al. Biologically relevant phenotypic changes and enhanced growth properties induced in B lymphocytes by an EBV strain derived from a histologically aggressive Hodgkin's disease. Int J Cancer 1999 ; 80 : 240-9.
23. Khanim F, Yao QY, Niedobitek G, Sihota S, Rickinson AB, Young LS. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumours from different geographic locations. Blood 1996 ; 88 : 491-501.
24. Hayashi K, Chen WG, Chen YY, et al. Deletion of Epstein-Barr virus latent membrane protein-1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue : high frequency of a 30-bp deletion. Hum Pathol 1997 ; 28 : 1408-14.
25. Hayashi K, Chen WG, Chen YY, et al. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes. Am J Pathol 1998 ; 152 : 191-8.
26. Itakura O, Yamada S, Narita M, Kikuta H. High prevalence of a 30-base pair deletion within the carboxy terminal end of the LMP-1 oncogene of Epstein-Barr virus in the Japanese population. Oncogene 1996 ; 13 : 1549-53.
27. Mansoor A, Stevenson MS, Li RZ, et al. Prevalence of Epstein-Barr viral sequences and EBV LMP1 oncogene deletions in Burkitt's lymphoma from Pakistan : epidemiological correlations. Hum Pathol 1997 ; 28 : 283-8.
28. Cheinfeld AG, Nador RG, Cesarman E, Chadburn A, Knowles DM. Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders. Am J Pathol 1997 ; 151 : 805-12.
29. Smir BN, Hauke RJ, Bierman PJ, et al. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders. Lab Invest 1996 ; 75 : 575-88.
30. Adldinger HK, Delius H, Freese UK, Clarke J, Bornkamm GW. A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes. Virology 1985 ; 141 : 221-34.
31. Rowe M, Young LS, Cadwallader K, Petti L, Kieff E, Rickinson AB. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. J Virol 1989 ; 63 : 1031-9.
32. Rickinson AB, Young LS, Rowe M. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J Virol 1987 ; 61 : 1310-7.
33. Young LS, Yao QY, Rooney CM, et al. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas. J Gen Virol 1987 ; 68 : 2853-62.
34. Boyle MJ, Vasak E, Tschuchnigg M, et al. Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease : association between B-type EBV and immunocompromise. Blood 1993 ; 81 : 468-74.
35. Boyle MJ, Sewell WA, Sculley TB, et al. Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma. Blood 1991 ; 78 : 3004-11.
36. Belkaid ML, Briere J, Djebbara Z, Beldjord K, Andrieu JM, Colonna P. Comparison of Epstein-Barr virus markers in Reed-sternberg cells in adult Hodgkin's disease tissues from an industrialized and a developing country. Leuk Lymphoma 1995 ; 17 : 163-8.
37. Korbi S, Trimeche M, Sriha B, et al. Epstein-Barr virus in Hodgkin's disease : the example of central Tunisia. Ann Pathol 2002 ; 22 : 96-101.
38. Edinger JW, Bonneville M, Scotet E, Houssaint E, Schumacher HR, Posnett DN. EBV gene expression not altered in rheumatoid synovia despite the presence of EBV antigen-specific T cell clones. J Immunol 1999 ; 162 : 3694-701.
39. Lin JC, Lin SC, De BK, Chan WP, Evatt B. Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER) : predominance of type A virus associated with Hodgkin's disease. Blood 1993 ; 81 : 3372-81.
40. Essop MF, Engel M, Close P, Sinclair-Smith C, Pallesen G. Epstein-barr virus in Hodgkin's disease : frequency of a 30-bp deletion in the latent membrane protein (LMP-1) oncogene in South African patients. Int J Cancer 1999 ; 84 : 449-51.
41. Zhou XG, Sandvej K, Li PJ, et al. Epstein-Barr virus gene polymorphisms in Chinese Hodgkin's disease cases and healthy donors : identification of three distinct virus variants. J Gen Virol 2001 ; 82 : 1157-67.
42. Dolcetti R, Zancai P, De Re V, et al. Epstein-Barr virus strains with latent membrane protein-1 deletions : Prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease. Blood 1997 ; 89 : 1723-31.
43. Kingma DW, Weiss WB, Jaffee ES, Kumar S, Frekko K, Raffeld M. Epstein-Barr virus latent membrane protein-1 oncogene deletions : correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996 ; 88 : 242-51.
44. Kaye KM, Izumi KM, Mosialos G, Kieff E. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation ; fibroblast cocultivation complements a critical function within the terminal 155 residues. J Virol 1995 ; 69 : 675-83.
45. Mitchell T, Sugden B. Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J Virol 1995 ; 69 : 2968-76.
46. Mosialos G, Birkenbach M, Yalamanchili R, Vanarsdale T, Ware C, Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 1995 ; 80 : 389-99.
47. Chiang AK, Wong KY, Liang AC, Srivastava G. Comparative analysis of Epstein-Barr virus gene polymorphisms in nasal T/NK-cell lymphomas and normal nasal tissues : implication on virus strain selection in malignancy. Int J Cancer 1999 ; 80 : 356-64.
48. Sandvej K, Gratama JW, Munch M, et al. Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region : identification of four variants among wild-type EBV isolates. Blood 1997 ; 90 : 323-30.
49. Krugmann J, Tzankov A, Gschwendtner A, et al. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma : a single-institution study. Mod Pathol 2003 ; 16 : 566-73.
50. Bellas C, Santon A, Manzanal A, et al. Pathological, immunological, and molecular features of Hodgkin's disease association with HIV infection. Comparison with ordinary Hodgkin's disease. Am J Surg Pathol 1996 ; 20 : 1520-4.
51. Tomita Y, Ohsawa M, Kanno H, et al. Epstein-Barr virus in Hodgkin's disease patients in Japan. Cancer 1996 ; 77 : 186-92.